The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion

Retrovirology

Volumn 5, Issue , 2008, Pages

  Sanders, Rogier W ^a   van Anken, Eelco ^b,c   Nabatov, Alexei A ^a,d   Marije, I Marije ^b,e   Bontjer, Ilja ^a   Eggink, Dirk ^a   Melchers, Mark ^a   Busser, Els ^a   Dankers, Martijn M ^a   Groot, Fedde ^a,f   Braakman, Ineke ^b   Berkhout, Ben ^a   Paxton, William A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CRUCELL HOLLAND BV   (Netherlands)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CARBOHYDRATE; CD4 ANTIGEN; GLYCOPROTEIN GP 120; MANNOSE; NEUTRALIZING ANTIBODY;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISULFIDE BOND; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; CHEMISTRY; GENETICS; HELA CELL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SERODIAGNOSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD4; ASPARAGINE; BINDING SITES; CARBOHYDRATES; DENDRITIC CELLS; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; NEUTRALIZATION TESTS; PROTEIN FOLDING;

EID: 40449129088     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-10     Document Type: Article

References (53)

1. Fennie C Lasky LA Model for intracellular folding of the human immunodeficiency virus type 1 gp120 J Virol 1989, 63:639-646 247734 2536098
2. Fenouillet E Gluckman JC Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein J Gen Virol 1991, 72 (Pt 8):1919-1926 1678778
3. Li Y Luo L Rasool N Kang CY Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding J Virol 1993, 67:584-588 237399 8416385
4. Geijtenbeek TB Kwon DS Torensma R van Vliet SJ van Duijnhoven GC Middel J Cornelissen IL Nottet HS KewalRamani VN Littman DR Figdor CG van Kooyk Y DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells Cell 2000, 100:587-597 10.1016/ S0092-8674(00)80694-7 10721995
5. Turville S Wilkinson J Cameron P Dable J Cunningham AL The role of dendritic cell C-type lectin receptors in HIV pathogenesis J Leukoc Biol 2003, 74:710-718 10.1189/jlb.0503208 12960229
6. Turville SG Cameron PU Handley A Lin G Pohlmann S Doms RW Cunningham AL Diversity of receptors binding HIV on dendritic cell subsets Nat Immunol 2002, 3:975-983 10.1038/ni841 12352970
7. Eggink D Melchers M Sanders RW Antibodies to HIV-1: Aiming at the right target Trends Microbiol 2007, 15:291-294 10.1016/j.tim.2007.05.006 17566740
8. Wei X Decker JM Wang S Hui H Kappes JC Wu X Salazar-Gonzalez JF Salazar MG Kilby JM Saag MS Komarova NL Nowak MA Hahn BH Kwong PD Shaw GM Antibody neutralization and escape by HIV-1 Nature 2003, 422:307-312 10.1038/nature01470 12646921
9. Calarese DA Scanlan CN Zwick MB Deechongkit S Mimura Y Kunert R Zhu P Wormald MR Stanfield RL Roux KH Kelly JW Rudd PM Dwek RA Katinger H Burton DR Wilson IA Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 2003, 300:2065-2071 10.1126/science.1083182 12829775
10. Sanders RW Venturi M Schiffner L Kalyanaraman R Katinger H Lloyd KO Kwong PD Moore JP The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120 J Virol 2002, 76:7293-7305 136300 12072528 10.1128/ JVI.76.14.7293-7305.2002
11. Scanlan CN Pantophlet R Wormald MR Ollmann SE Stanfield R Wilson IA Katinger H Dwek RA Rudd PM Burton DR The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1→2 mannose residues on the outer face of gp120 J Virol 2002, 76:7306-7321 136327 12072529 10.1128/JVI.76.14.7306-7321.2002
12. Trkola A Purtscher M Muster T Ballaun C Buchacher A Sullivan N Srinivasan K Sodroski J Moore JP Katinger H Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J Virol 1996, 70:1100-1108 189917 8551569
13. Shan M Klasse PJ Banerjee K Dey AK Iyer SP Dionisio R Charles D Campbell-Gardener L Olson WC Sanders RW Moore JP HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells PLoS Pathog 2007, 3:e169 2048530 17983270 10.1371/journal.ppat.0030169
14. Nabatov AA Pollakis G Linnemann T Kliphius A Chalaby MI Paxton WA Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies J Virol 2004, 78:524-530 303404 14671134 10.1128/ JVI.78.1.524-530.2004
15. Pollakis G Kang S Kliphuis A Chalaby MI Goudsmit J Paxton WA N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization J Biol Chem 2001, 276:13433-13441 10.1074/jbc.M009779200 11278567
16. Sanders RW The HIV-1 envelope glycoproteins: Folding, function and vaccine design (Ph.D. thesis University of Amsterdam) Amsterdam, Amsterdam University Press 2004
17. Leonard CK Spellman MW Riddle L Harris RJ Thomas JN Gregory TJ Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in chinese hamster ovary cells J Biol Chem 1990, 265(18):10373-10382
18. Land A Zonneveld D Braakman I Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage FASEB J 2003, 17:1058-1067 10.1096/fj.02-0811com 12773488
19. Trombetta ES Parodi AJ Quality control and protein folding in the secretory pathway Annu Rev Cell Dev Biol 2003, 19:649-676 10.1146/ annurev.cellbio.19.110701.153949 14570585
20. Kornfeld R Kornfeld S Assembly of asparagine-linked oligosaccharides Ann Rev Biochem 1985, 54:631-664 10.1146/annurev.bi.54.070185.003215 3896128
21. Burton DR Pyati J Koduri R Sharp SJ Thornton GB Parren PW Sawyer LS Hendry RM Dunlop N Nara PL Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody Science 1994, 266:1024-1027 10.1126/science.7973652 7973652
22. Roben P Moore JP Thali M Sodroski J Barbas CF III Burton DR Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 J Virol 1994, 68:4821-4828 236421 7518527
23. Pantophlet R Ollmann SE Poignard P Parren PW Wilson IA Burton DR Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120 J Virol 2003, 77:642-658 140633 12477867 10.1128/JVI.77.1.642-658.2003
24. Roos JW Maughan MF Liao Z Hildreth JE Clements JE LuSIV cells: A reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication Virol 2000, 273:307-315 10.1006/viro.2000.0431
25. Baribaud F Pohlmann S Leslie G Mortari F Doms RW Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells J Virol 2002, 76:9135-9142 136426 12186897 10.1128/ JVI.76.18.9135-9142.2002
26. Turville SG Arthos J Donald KM Lynch G Naif H Clark G Hart D Cunningham AL HIV gp120 receptors on human dendritic cells Blood 2001, 98:2482-2488 10.1182/blood.V98.8.2482 11588046
27. Turville SG Cameron PU Arthos J MacDonald K Clark G Hart D Cunningham AL Bitter-sweet symphony: Defining the role of dendritic cell gp120 receptors in HIV infection J Clin Virol 2001, 22:229-239 10.1016/ S1386-6532(01)00194-9 11564587
28. Hong PW Nguyen S Young S Su SV Lee B Identification of the optimal DC-SIGN binding site on human immunodeficiency virus type 1 gp120 J Virol 2007, 81:8325-8336 1951277 17522223 10.1128/JVI.01765-06
29. Gray ES Moore PL Pantophlet RA Morris L N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization J Virol 2007, 81:10769-10776 2045459 17634239 10.1128/JVI.01106-07
30. Zhou T Xu L Dey B Hessell AJ Van Ryk D Xiang SH Yang X Zhang MY Zwick MB Arthos J Burton DR Dimitrov DS Sodroski J Wyatt R Nabel GJ Kwong PD Structural definition of a conserved neutralization epitope on HIV-1 gp120 Nature 2007, 445:732-737 10.1038/nature05580 17301785
31. Koch M Pancera M Kwong PD Kolchinsky P Grundner C Wang L Hendrickson WA Sodroski J Wyatt R Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition Virol 2003, 313:387-400 10.1016/S0042-6822(03)00294-0
32. Kolchinsky P Kiprilov E Sodroski J Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants J Virol 2001, 75:2041-2050 114788 11160708 10.1128/JVI.75.5.2041-2050.2001
33. Bolmstedt A Sjolander S Hansen JE Akerblom L Hemming A Hu SL Morein B Olofsson S Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:213-220 8673525
34. Bolmstedt A Hinkula J Rowcliffe E Biller M Wahren B Olofsson S Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan Vaccine 2001, 20:397-405 10.1016/S0264-410X(01)00358-9 11672902
35. Chakrabarti BK Kong WP Wu BY Yang ZY Friborg J Ling X King SR Montefiori DC Nabel GJ Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization J Virol 2002, 76:5357-5368 137015 11991964 10.1128/JVI.76.11.5357-5368.2002
36. Li Y Cleveland B Klots I Travis B Richardson BA Anderson D Montefiori D Polacino P Hu SL Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses J Virol 2008, 82:638-651 10.1128/ JVI.01691-07 17959660
37. Quinones-Kochs MI Buonocore L Rose JK Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: Effects on protein function and the neutralizing antibody response J Virol 2002, 76:4199-4211 155056 11932385 10.1128/JVI.76.9.4199-4211.2002
38. Reitter JN Means RE Desrosiers RC A role for carbohydrates in immune evasion in AIDS Nat Med 1998, 4:679-684 10.1038/nm0698-679 9623976
39. Reynard F Willkomm N Fatmi A Vallon-Eberhard A Verrier B Bedin F Characterization of the antibody response elicited by HIV-1 Env glycomutants in rabbits Vaccine 2007, 25:535-546 10.1016/ j.vaccine.2006.07.051 16934377
40. Sanders RW Busser E Moore JP Lu M Berkhout B Evolutionary repair of HIV type 1 gp41 with a kink in the N-terminal helix leads to restoration of the six-helix bundle structure AIDS Res Hum Retroviruses 2004, 20:742-749 10.1089/0889222041524544 15307920
41. Peden K Emerman M Montagnier L Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI Virol 1991, 185:661-672 10.1016/ 0042-6822(91)90537-L
42. Sanders RW de Jong EC Baldwin CE Schuitemaker JH Kapsenberg ML Berkhout B Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells J Virol 2002, 76:7812-7821 136398 12097593 10.1128/JVI.76.15.7812-7821.2002
43. Das AT Klaver B Berkhout B A hairpin structure in the R region of the Human Immunodeficiency Virus type 1 RNA genome is instrumental in polyadenylation site selection J Virol 1999, 73:81-91 103811 9847310
44. Jeeninga RE Hoogenkamp M Armand-Ugon M de Baar M Verhoef K Berkhout B Functional differences between the long terminal repeat transcriptional promoters of HIV-1 subtypes A through G J Virol 2000, 74:3740-3751 111883 10729149 10.1128/JVI.74.8.3740-3751.2000
45. Groot F Geijtenbeek TB Sanders RW Baldwin CE Sanchez-Hernandez M Floris R van Kooyk Y de Jong EC Berkhout B Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN - gp120 interaction J Virol 2005, 79:3009-3015 548463 15709021 10.1128/JVI.79.5.3009-3015.2005
46. Sanders RW Dankers MM Busser E Caffrey M Moore JP Berkhout B Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41 Retrovirology 2004, 1:3 416572 15169554 10.1186/1742-4690-1-3
47. Das AT Klaver B Klasens BIF van Wamel JLB Berkhout B A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication J Virol 1997, 71:2346-2356 191344 9032371
48. Derdeyn CA Decker JM Sfakianos JN Wu X O'Brien WA Ratner L Kappes JC Shaw GM Hunter E Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 J Virol 2000, 74:8358-8367 116346 10954535 10.1128/JVI.74.18.8358-8367.2000
49. Wei X Decker JM Liu H Zhang Z Arani RB Kilby JM Saag MS Wu X Shaw GM Kappes JC Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy Antimicrob Agents Chemother 2002, 46:1896-1905 127242 12019106 10.1128/ AAC.46.6.1896-1905.2002
50. Groot F van Capel TM Kapsenberg ML Berkhout B de Jong EC Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: Transmission facilitation versus replication inhibition Blood 2006, 108:1957-1964 10.1182/blood-2006-03-010918 16705088
51. Moore JP Ho DD Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans J Virol 1993, 67:863-875 237440 7678308
52. Fuerst TR Niles EG Studier FW Moss B Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase Proc Natl Acad Sci U S A 1986, 83:8122-8126 386879 3095828 10.1073/pnas.83.21.8122
53. Kwong PD Wyatt R Robinson J Sweet RW Sodroski J Hendrickson WA Structure of an HIV gp120 envelope glycoprotein in a complex with the CD4 receptor and a neutralizing human antibody Nature 1998, 393:648-659 10.1038/31405 9641677